Please assess the completion status of the following clinical trial:

Trial Title: Organoid Model Predictive of Response to Immunotherapies

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. ≥ 18 years old at the time of informed consent~2. Ability to provide written informed consent and HIPAA authorization~3. Biopsy proven diagnosis of cancer~4. Able to obtain at least 2 16 gage cores of fresh tissue safely (3 or more cores preferred)~5. Planning to undergo standard of care Immunotherapy~6. Baseline standard of care CT within 8 weeks of starting Immunotherapy~Exclusion Criteria:~1. Inability to provide fresh biopsy sample~2. Any active infections~3. Any conditions that in the opinion of treating physician and the study team will compromise the ability of the patient to receive prescribed treatment to assess the response.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).